The Translational Partner for Cell Therapy

Let’s Discuss Your Project
Hero

ABOUT US

We make your science manufacturable

NueCell Bio is the San Diego-based translational partner for advanced cell therapies. We are the dedicated team bridging discovery and GMP manufacturing, uniquely equipped to accelerate the delivery of life-changing treatments to patients. At the core of our approach is NueStack™ – our modular technology stacks that can be configured to each program’s unique needs, providing a faster, lower-risk route to transitioning from laboratory research to GMP-compliant manufacturing.

Why NueCell Bio?

Our team brings deep cell therapy expertise, a proven track record, and a demonstrated history of successful on-time program execution. Specifically, we facilitate the delivery of cell products at the scale, viability, quality and consistency required to support the manufacture of safe and effective transformative treatments for a wide range of diseases. Our combined cell therapy industry experience, active leadership in global standards initiatives and peer-reviewed publications translate into a program-level discipline that keeps your science on track from project start to GMP manufacturing.

Early decisions define success

Cell therapy success, particularly for complex programs, is determined by decisions made long before GMP manufacturing. Choices regarding program design, cell engineering, process development, analytical strategy, cell banking, quality, and supply chain lay the foundation for manufacturability, scalability, and regulatory readiness. From early feasibility through GMP technology transfer, we provide integrated expertise across each of these disciplines to reduce risk, avoid costly downstream changes, and accelerate the path to the clinic.

Proven stacks you can lean on

NueStack™ is our library of proven, modular technology stacks, deployed across modalities and ready to genetically engineer cells with the characteristics needed to treat specific diseases, and to configure processes to your scale, workflow, and target product profile. Your program begins on a proven foundation —not from a blank page—delivering cells in quantities with the characteristics and viability needed for medical intervention.

Unrivaled scientific & CMC perspective

160+ years of combined experience and more than 150 peer-reviewed publications covering cell engineering, gene editing, process development, standardization, and analytics across iPSC, gene editing, CAR-T, NK, MSC, and stem cells. Our clients seek our expertise to guide decision making that leads to successful cell therapy programs.

OUR CLIENTS

Built to Serve Innovators

NueCell Bio adapts to your needs by providing integrated development support that complements your team and advances your program toward the clinic.

Our flexible engagement model enables us to support organizations across the cell therapy ecosystem—from academia and emerging biotechs to mid-sized and global biopharma companies. Purpose-built as your catalyst to GMP, the NueStack™ technology modules, material choices, and analytical approaches are assembled purposefully to establish transferable GMP manufacturing-ready processes and analytics.

Through our nimble, program-based engagement model, NueCell Bio provides access to experienced scientific, development and CMC expertise. By combining scientific excellence, strong quality systems, scalable operations, and customer-first engagement, NueCell Bio helps accelerate the journey from scientific discovery to clinical delivery.

Expertise

OUR EXPERTISE

Wide-Ranging Modality Expertise

Cell therapy innovation is advancing rapidly, and developers are pursuing varied approaches. NueCell's expert team and modular, modality-agnostic technology stacks are designed to make your science manufacturable wherever it leads.

Cell Types

  • Primary cells (T, NK, Myeloid, etc)
  • Stem & progenitor cells (HSC, PSC, MSC, etc)
  • Specialized cells (differentiated stem cells, primary therapeutic cells)

Product Architecture

  • Autologous
  • Allogeneic
  • Adherent
  • Suspension
  • Scale-up
  • Scale-out

Engineering Capabilities

  • Gene editing (CRISPR, ZFN, TALEN)
  • Viral delivery
  • Non-viral delivery (LNP, Liposome, Electroporation)
  • Cellular reprogramming

OUR CAPABILITIES

State-of-the-Art Capabilities

NueCell Bio operates a purpose-built, 26,300-square-foot development facility in San Diego's Sorrento Valley, designed to transform scientific innovation into manufacturable cell therapies. Certified to ISO 9001 standards, the laboratories support the development lifecycle from program design and feasibility through cell engineering, cell banking, process and analytical development and GMP transfer readiness.

Purpose-built as your catalyst to GMP, the NueStack™ technology modules, material choices, and analytical approaches are assembled to establish transferable, GMP-manufacturing-ready processes and analytics. Comprehensive documentation, traceability, and operational excellence enable multiple client programs to progress in parallel while supporting rapid iteration, informed decision-making, and the efficient transfer of scalable, reproducible manufacturing processes to GMP production.

1

Program design & feasibility

Workflow selection, equipment, raw materials, and fit-for-purpose analytics are chosen for your modality from day one.

2

Cell engineering

Somatic cell reprogramming, CRISPR/ZFN/TALEN gene editing, and characterized research cell banks. Tissue engineering (scaffold, biomaterials, and engineered tissues).

3

Manufacturing process design, feasibility, and development

Bench-to-clinic process design, scale-up/scale-down modeling, unit operations optimization, and process lock for GMP transfer.

4

Analytical design, development, and testing

Qualifiable assays developed alongside the process to ICH Q2(R2) standards, with in-process control. Fit-for-purpose testing to support product and process characterization, in-process controls and GMP transfer-ready methods with appropriate controls and standards.

5

Cell banking

ISO 9001 research cell banking with full characterization, traceability, and GMP-transfer documentation.

6

Quality, supply chain & logistics

Raw material sourcing, vendor qualification, cold chain, documentation, and draft batch records.

7

GMP manufacturing preparation and technology transfer

Manufacturing readiness through process and analytical method transfer packages, draft batch records, risk assessments, and technology transfer documentation to enable successful GMP implementation and to support future regulatory submissions.

CONTACT US

Let’s Discuss Your Project

The NueCell Bio team is ready to translate your cell therapy discovery into clinical and commercial reality. Tell us about your program below

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Consent